Edwards Lifesciences (EW) Short term Debt (2009 - 2018)

Edwards Lifesciences' Short term Debt history runs 7 years deep, the most recent figure standing at $598.6 million for Q1 2018.

• In Q1 2018, Short term Debt changed N/A year-over-year to $598.6 million; the TTM figure through Mar 2018 stood at $598.6 million (changed N/A YoY), while the FY2017 annual figure was $51.7 million, changed N/A from the prior year.
• Short term Debt was $598.6 million for Q1 2018 at Edwards Lifesciences, up from $51.7 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $598.6 million in Q1 2018 to a low of $2.2 million in Q3 2014.
• Historically, Short term Debt has averaged $139.3 million across 3 years, with a median of $41.5 million in 2017.
• Biggest YoY gain for Short term Debt was 80.15% in 2014; the steepest drop was 80.15% in 2014.
• A 3-year view of Short term Debt shows it stood at $2.6 million in 2014, then surged by 1888.46% to $51.7 million in 2017, then jumped by 1057.83% to $598.6 million in 2018.
• The last three Short term Debt figures came in at $598.6 million (Q1 2018), $51.7 million (Q4 2017), and $41.5 million (Q3 2017), per Business Quant data.